YGYasemin Gündoğdu

Yasemin Gündoğdu

*This is an algorithmically generated author record based on publicly available information.

Yasemin Gündoğdu has a total of 1000 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    First Reported Case of Prosthetic Joint Infection Caused by an Unusual Bacterium: Neisseria macacae

    by Yeşim Beşli, Sinem Öktem-Okullu, Yasemin Gündoğdu, Orhan Cem Deniz

    Acute non-traumatic joint pain, swelling, and fever require prompt evaluation for a prosthetic joint infection, a serious bacterial complication affecting both large and small joints. Neisseria gonorrhoeae and Staphylococcus aureus are among the most common causes, typically involving a single joint. To the best of our knowledge, we report the first case of a prosthetic joint infection caused by Neisseria macacae, highlighting its relevance for differential diagnosis. Identification was achieved using MALDI-TOF and confirmed with next-generation sequencing. While N. gonorrhoeae and Neisseria meningitidis are well-recognized pathogens, other Neisseria species may cause opportunistic infections, underscoring the importance of comprehensive microbiological evaluation.


  • Open Access

    C-reactive Protein Guided Empirical Antibiotic Therapy Versus Standardized Neutropenic Fever Approach in Patients Undergoing High-dose Chemotherapy Followed by Autologous Stem Cell Transplantation

    by Ant Uzay, Yasemin Gündoğdu, Cemal Üstün, Yıldız Okuturlar, Nigar Rustamova Cennet, Hatun Gür, Tuğba Yetiş, Barış Koşan, Süleyman Sami Kartı

    C-reactive Protein Guided Empirical Antibiotic Therapy Versus Standardized Neutropenic Fever Approach in Patients Undergoing High-dose Chemotherapy Followed by Autologous Stem Cell Transplantation - Medical Journal of Bakirkoy

  • Open Access

    Treosulfan is a safe and effective alternative to busulfan for conditioning in adult allogeneic HSCT patients: Data from a single center

    by Ant Uzay, Yasemin Gündoğdu, Barış Koşan, Tuğba Yetiş, S. Sami Kartı

    Introduction: Type of conditioning regimen impacts the outcome of patients who undergo allogeneic HSCT since graft versus host disease (GVHD), infections, regimen related toxicities (RRT) are important causes of post‐transplant mortality. Despite the RRT profile of busulfan, it is frequently used worldwide. Treosulfan has advantages in terms of dose of administration, lower incidence of sinusoidal obstruction syndrome and lower neurotoxicity. We retrospectively investigated outcomes of patients who underwent allogeneic HSCT with treosulfan or busulfan based conditioning regimens in our institution.Methods: Treosulfan was administered to 94 patients while 85 patients received busulfan. Our outcomes were RRT, chronic and acute GVHD, relapse related mortality (RRM), non‐relapse mortality, and fungal infection. The clinical follow up data, regarding the primary and secondary endpoints of our study, of the patients who received treosulfan or busulfan based conditioning regimens were statistically analyzed.Results: The median follow‐up was 14 months for the treosulfan group while it was 11 months for the busulfan group (p = 0.16). RRT was 11.7% and 7.1% for treosulfan and busulfan respectively. The incidence of extensive chronic GVHD was less frequent in the treosulfan group compared to the busulfan group (15.7% vs. 32.1%) (p < 0.001). The incidence of acute GVHD (Grade 3 or higher) was 32.2% in the treosulfan group while it was 31.6% in the busulfan group. The RRM was 17% in the treosulfan group while it was 34% in the busulfan group. The non‐relapse mortality was 35.5% and 29.4% in the treosulfan group and in the busulfan group respectively (p = 0.962).Conclusion: Treosulfan, with a lower RRM, lower chronic GVHD incidence and with a similar RRT profile appears to be a safe alternative to busulfan.


  • Open Access

    Evaluation of Interleukin 6 Levels in Severe COVID-19 Patients

    by Yıldız Okuturlar, İftihar Köksal, Yasemin Gündoğdu, Arzu Yüksel, Özgür Okuturlar, Fadıl HAVAS, Cem Gun

    Objectives: Interleukin 6 (IL-6) plays a leading role in the proliferation and differentiation of immune cells. Level of IL-6 is manifestly increased under many inflammatory conditions, including cytokine release syndrome. We evaluated the IL-6 levels of patients who were hospitalized with the diagnosis of COVID-19. Methods: In the study, the test results of 19 cases whose IL-6 levels were measured between March 11, 2020 and May 31, 2020 retrospectively. The inpatients in the covid service (Group 1) and the patients admitted to the Intensive Care Unit (ICU) of our hospital (Group 2) were compared and evaluated. In addition, patients with positive and negative RT-PCR test results were checked for IL-6. Results: While 8 (Group 1) of 19 patients observed in the clinic were transferred to the ICU, 11 patients (Group 2) were observed in the covid service until their discharge. Group 1 IL-6 levels (median 34 pg/mL) and Group 2 IL-6 levels (median 116 pg/mL) were found to be high in both groups (p = 0,099). However, it was found to be significantly higher in patients with positive COVID-19 RT-PCR test (median 90.60 pg/mL) than in negative patients (median 29.90 pg/mL) (p = 0.018). Conclusion: No significant difference in IL-6 levels between the patients who were monitored in the clinic and transferred to the ICU was found in this study. The significant difference between IL-6 levels among COVID-19 RT-PCR positive and negative patients reveals the importance of IL-6 level with regard to tocilizumab treatment in COVID-19 patients in cytokine storm. Keywords: COVID-19, Interleukin 6, Cytokine Storm, Macrophage Activation Syndrome


  • Daily low dose intravesical cidofovir for the treatment of BK virus associated hemorrhagic cystitis after allogeneic stem cell transplantation

    by Ant Uzay, Yasemin Gündoğdu, Barış Koşan, Tuğba Yetiş, Hatun Gür, Yildiz Okuturlar, S. Sami Kartı


  • Open Access

    Effects of hospital facilities on patient outcomes after cancer surgery: an international, prospective, observational study

    by Catherine A Shaw, Riinu Pius, Thomas M Drake, Lisa Norman, Adesoji O Ademuyiwa, Adewale O Adisa, Maria Lorena Aguilera, Sara W Al-Saqqa, Ibrahim Al-Slaibi, Aneel Bhangu, et al.


  • Sunitinib induced colitis manifesting as invasive diarrhea in a patient with renal cell carcinoma

    by Yasemin Gündoğdu, Orhan Cem Deniz, Didem Saka, Gürhan Şişman, Sibel Erdamar, İfTihar Köksal

    Introduction: Sunitinib is a tyrosine kinase inhibitor that binds to vascular endothelial factor receptor currently used for the treatment of renal cell carcinoma, as well as for several other conditions such as gastrointestinal stromal tumors and pancreatic neuroendocrine tumors. We present a patient with invasive diarrhea who was treated with sunitinib for metastatic renal cell carcinoma. Case report: Drug induced colitis was confirmed with colonoscopy from histopathological specimens. Clinical recovery of diarrhea was achieved with oral budesonide. Remarkably, the pathologic findings were observed in both the macroscopically normal mucosa and the mucosa with aphthous ulcers in the colon. Management & outcome: The patient was treated for sunitinib associated diarrhea, after exclusion of the other reasons. Metronidazole and piperacillin/tazobactam treatment were prescribed. Discussion: Diarrhea is a frequent symptom in patients treated with tyrosine kinase inhibitors, however the described pathologic findings have rarely been reported. Our aim is to emphasize the importance of close follow-up in patients treated with tyrosine kinase inhibitors, and to raise awareness on the management of sunitinib induced colitis.


  • Presenting Characteristics and ICU Admission Among Patients Hospitalized with COVID-19

    by Aral Sürmeli, Öykü Beyaz, Elif Sitre Koç, Yasemin Gündogdu, Çaglar Çuhadaroglu, Sesin Kocagöz

    Objective: Information on characteristics and outcomes of coronavirus disease 2019 (COVID-19) patients in Turkey is limited. We aimed to describe the characteristics and outcomes of patients hospitalised with COVID-19 and compare patients who required intensive care unit (ICU) admission with those who did not require it. Materials and Methods: This retrospective cross-sectional study was conducted in a tertiary care hospital in Istanbul. A total of 215 patients hospitalised with COVID-19 between 9 March 2020 and 30 April 2020 were included. Demographic, clinical, laboratory and radiological data on admission and outcomes were analysed. The main outcomes were COVID-19 ward or ICU hospitalisation, invasive mechanical ventilation requirement, discharge, or death. Presenting characteristics were compared between patients who required ICU admission with those who did not require it. Results: Among 215 patients, 64% were male, and the median age was 53. The most prevalent comorbidity was hypertension, followed by diabetes mellitus and coronary artery disease. The prevalence of comorbidities and the median age was higher in patients in ICU. The most common presenting symptom was fever (72%). C-reactive protein (CRP), lactate dehydrogenase (LDH), neutrophil and lymphocyte count, ferritin, and d-dimer levels were significantly different between ICU and non-ICU patients. However, in the final logistic model, among presenting symptoms, initial radiographs and laboratory tests, having dyspnea, high CRP and LDH were significantly associated with ICU admission. Conclusion: Of 215 hospitalised patients with COVID-19, 17% of patients required ICU admission, and the mortality rate was 4.4%. Older age, having coronary artery disease, high levels of CRP, LDH, and presenting with dyspnea were significantly associated with ICU admission. Keywords: Infections, Pneumonia, Critical Care


  • Open Access

    Pectoral muscle hematoma as a complication of Covid-19 treatment: A Case Report

    by Yıldız Okuturlar, Damla Gürleyi̇k, Nur Ramoğlu, Yasemin Gündoğdu, İftihar Köksal

    In COVID-19 disease, the activation of the coagulation system is increasing. Here we presented a case of COVID-19 who developed a hematoma in the pectoral muscle possibly associated with anticoagulation therapy.